4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-22-005750
Chief Development Officer sold 1,732 shares at an average $4.30 ($7,455)
From the SEC's structured data for this filing
Trades in this filing
LeBel Carl · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-16 | Sale : show line 1 in the form | −831 | $4.43 | $3,680 | 14,070 | D |
| 2022-02-17 | Sale : show line 2 in the form | −901 | $4.19 | $3,774 | 13,169 | D |
| Open-market sales · 1,732 sh · avg $4.30 · $7,455 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2022-02-17 | Grant or award : show line 3 in the form Restricted Stock Unit | +150,000 | 150,000 | 150,000 | D |
Loading xslF345X03/form4.xml…